About Pavel Khrimian
Form D filings for Deka Biosciences from 2021 to 2023 list Pavel Khrimian as executive officer.
Pavel Khrimian first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Pavel Khrimian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Pavel Khrimian works with at each company, as listed on that company's latest Form D.
Deka Biosciences, Inc. · Form D, Dec 8, 2023
JM
John Mumm
Chief Executive Officer and director
DB
Detlev Biniszkiewicz
Director
LH
Lu Han
Director
CY
Christopher Yaen
Executive officer
Rakhshita Dhar
Director
PB
Peter Buzy
Director